Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography

被引:47
|
作者
Scappaticcio, Lorenzo [1 ,2 ,3 ]
Trimboli, Pierpaolo [2 ,3 ]
Keller, Franco [4 ]
Imperiali, Mauro [4 ]
Piccardo, Arnoldo [5 ]
Giovanella, Luca [2 ,3 ,4 ,6 ,7 ]
机构
[1] Univ Campania L Vanvitelli, Unit Endocrinol & Metab Dis, Naples, Italy
[2] Imaging Inst Southern Switzerland, Clin Nucl Med, Bellinzona, Switzerland
[3] Imaging Inst Southern Switzerland, Competence Thyroid Ctr, Bellinzona, Switzerland
[4] Ente Osped Cantonale, Inst Lab Med, Bellinzona, Switzerland
[5] Ente Osped Galliera, Div Nucl Med, Genoa, Italy
[6] Univ Hosp, Clin Nucl Med, Zurich, Switzerland
[7] Univ Zurich, Zurich, Switzerland
关键词
hyperthyroidism; thyroid scintigraphy; thyroid ultrasonography; thyroid-stimulating immunoglobulins (TSI); thyrotropin receptor antibodies (TRAb); DIFFERENTIAL-DIAGNOSIS; PAINLESS THYROIDITIS; CLINICAL UTILITY; CUTOFF VALUE; DISEASE; ASSAY; POPULATION; MANAGEMENT; BIOASSAYS; FLOW;
D O I
10.1111/cen.14130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Graves' disease (GD) is the most common cause of hyperthyroidism. In many cases, when the aetiological diagnosis of GD is not evident based on the clinical evaluation and thyroid function testing, it may become challenging to distinguish Graves' hyperthyroidism from other forms of thyrotoxicosis. The current study was primarly carried out to compare the diagnostic effectiveness of two TSH receptor antibody immunoassays (IMAs), ultrasonography and thyroid scintigraphy in hyperthyroidism scenario. Methods: We retrospectively analysed consecutive patients with newly diagnosed and untreated thyrotoxicosis who underwent thyroid functional tests, both TRAb and TSI measurements, thyroid scintigraphy and ultrasonography. TRAb assessment was carried out by Kryptor (R) compact PLUS, while TSI by Immulite (R). Echo pattern 3 corresponded to 'thyroid inferno', and the final diagnosis of GD vs non-Graves' hyperthyroidism was made according to the thyroid scan (qualitative scintigraphy). Receiver operating characteristic (ROC) curves were drawn using the final diagnosis as reference. Clinical sensitivity and specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) were calculated for all the tests. Results: A total of 124 untreated hyperthyroid patients were included in our study (GD, n = 86 vs non-Graves' hyperthyroidism, n = 38). ROC curves showed that the optimal cut-off values associated with the highest diagnostic sensitivity and specificity was 0.7 IU/L for TRAb Kryptor (R) (93 [85.4-97.4] and 86.8 [71.9-95.5]) and 0.1 IU/L for TSI Immulite (R) (94.2 [86.9-98.1] and 84.2 [68.7-93.9]), respectively. For the echo pattern 3, we found a good sensitivity (92.1%) and a high PPV (95.2%) but a quite low specificity value (69.8%) and a relative low NPV (57.5%). For thyroid scintigraphy, the TcTU cut-off value of 1.3% corresponded to the best limit for sensitivity and specificity in our patients (95.3 [88.5-98.7] and 96.4 [81.6-99.4]). The Passing-Bablok regression equation and the Bland-Altman test showed a great degree of correlation and agreement existed between TRAb Kryptor (R) and Immulite (R) TSI results. Conclusions: Thyroid scintigraphy remains the most accurate method to differentiate causes of thyrotoxicosis. However, TRAb assays can be alternatively adopted in this setting, limiting the use of thyroid scintigraphy (TcTU evaluation) to TRAb-negative patients. Thyoid US is less accurate than both TRAb/TSI and thyroid scintigraphy, but the 'thyroid inferno' pattern provides a high PPV for GD.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 36 条
  • [21] Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves’ disease
    Raghavendran Priyanka
    Subbiah Sridhar
    Baskaran Sumathi
    Ashok Raja Jeyaraj
    Vasanthiy Natarajan
    Eagappan Subbiah
    Kasthuri Santharam Raghavan
    Jayaraman Sangumani
    Endocrine, 2024, 84 : 500 - 508
  • [22] Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment
    Takasu, N
    Yamashiro, K
    Komiya, I
    Ochi, Y
    Sato, Y
    Nagata, A
    THYROID, 2000, 10 (10) : 891 - 896
  • [23] Graves' disease following thyrotoxic painless thyroiditis. Analysis of antibody activities against the thyrotropin receptor in two cases
    Sarlis, NJ
    Brucker-Davis, F
    Swift, JP
    Tahara, K
    Kohn, LD
    THYROID, 1997, 7 (06) : 829 - 836
  • [24] Differential evolution of thyroid peroxidase and thyrotropin receptor antibodies in Graves' disease: Thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal
    Guilhem, Isabelle
    Massart, Catherine
    Poirier, Jean-Yves
    Maugendre, Didier
    THYROID, 2006, 16 (10) : 1041 - 1045
  • [25] Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease
    Akuzawa, M
    Murakami, M
    Yamada, M
    Satoh, T
    Shimizu, H
    Mori, M
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (03) : 281 - 285
  • [26] Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves'disease
    Hirooka, Y
    Li, C
    Takagi, J
    Gotoh, M
    Habu, S
    Yasaka-Nomura, T
    Ishihara, R
    Nakasone, Y
    Nakamura, R
    Morikawa, R
    Otake, K
    Nogimori, T
    Ishizuki, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2004, 24 (04) : 111 - 116
  • [27] Preoperative change of thyroid stimulating hormone receptor antibody level: Possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy
    Sugino, K
    Mimura, T
    Ozaki, O
    Iwasaki, H
    Wada, N
    Matsumoto, A
    Ito, K
    WORLD JOURNAL OF SURGERY, 1996, 20 (07) : 801 - 807
  • [28] Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves' orbitopathy patients: a comparison with two commonly used immunoassays
    Hotte, Gijsbert J.
    de Bie, Maaike
    de Keizer, Ronald O. B.
    Kolijn, P. Martijn
    Drexhage, Roosmarijn C.
    Veenbergen, Sharon
    Versnel, Marjan A.
    van Hagen, P. Martin
    Paridaens, Dion
    Dik, Willem A.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [29] Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: Evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period
    Carella, C
    Mazziotti, G
    Sorvillo, F
    Piscopo, M
    Cioffi, M
    Pilla, P
    Nersita, R
    Iorio, S
    Amato, G
    Braverman, LE
    Roti, E
    THYROID, 2006, 16 (03) : 295 - 302
  • [30] A SYNTHETIC OLIGOPEPTIDE DERIVED FROM HUMAN THYROTROPIN RECEPTOR SEQUENCE BINDS TO GRAVES IMMUNOGLOBULIN AND INHIBITS THYROID STIMULATING ANTIBODY-ACTIVITY BUT LACKS INTERACTIONS WITH TSH
    MORI, T
    SUGAWA, H
    PIRAPHATDIST, T
    INOUE, D
    ENOMOTO, T
    IMURA, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (01) : 165 - 172